Chemokines: key players in cancer

References

• Yoshimura T, Matsushima K, Oppenheim JJ, Leonard EJ. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leucocytes: partial characterization and separation from interleukin-1 (IL-1). J Immunol 1987;139:788–93
   PubMed Web of Science ®Google Scholar
• Walz A, Perveri P, Aschauer H, Baggiolini. Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes. Biochem Bioiophys Res Commun 1987;149:755–61
   PubMed Web of Science ®Google Scholar
• Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001;410:50–6
   PubMed Web of Science ®Google Scholar
• Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines – CXC and CC chemokines. Adv Immunol 1994;55: 97–179
   PubMed Web of Science ®Google Scholar
• Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol 1997;15:675–705
   PubMed Web of Science ®Google Scholar
• Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000;18:217–42
   PubMed Web of Science ®Google Scholar
• Murphy PM. The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol 1994;12:593
   PubMed Web of Science ®Google Scholar
• Murphy PM, Baggiolini M, Charo IF, Hebert CA, Horuk R, Matsushima K, Miller LH, Oppenheim JJ, Power CA. International Union of Pharmacology. XXII. Nomenclature for chemokines receptors. Pharmacol Rev 2000;52:145–76
   PubMed Web of Science ®Google Scholar
• Bais C, Santomasso B, Coso O, Arvanitakis L, Raaka EG, Gutkind JS, Asch AS, Cesarman E, Gershengorn MC, Mesri EA, Gerhengorn MC. G-protein-coupled receptor of Kaposi’s sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 1998;391:86–9
   PubMed Web of Science ®Google Scholar
• Yang TY, Chen SC, Leach MW, Manfra D, Homey B, Wiekowski M, Sullivan L, Jenh CH, Narula SK, Chensue SW, Lira SA. Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi’s sarcoma. J Exp Med 2000;191: 445–54
   PubMed Web of Science ®Google Scholar
• Burger M, Burger JA, Hoch RC, Oades Z, Takamori H, Schraufstatter IU. Point mutation causing constitutive signaling of CXCR2 leads to transforming activity similar to Kaposi’s sarcoma herpesvirus-G protein-coupled receptor. J Immunol 1999;163:2017–22
   PubMed Web of Science ®Google Scholar
• Gospodarowicz D. Growth factors and their action in vivo and in vitro. J Pathol 1983;141:201–33
   PubMed Web of Science ®Google Scholar
• Antoniades HN, Owen AJ. Growth factors and regulation of cell growth. Annu Rev Med 1982;33:445–63
   PubMed Web of Science ®Google Scholar
• Schadendorf D, Moller A, Algermissen B, Worm M, Sticherling M, Czarnetzki BM. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J Immunol 1993;151:2267–75
   Google Scholar
• Moser B, Barella L, Mattei S, Schumacher C, Boulay F, Colombo MP, Baggiolini M. Expression of transcripts for two interleukin-8 receptors in human phagocytes, lymphocytes, and melanoma cells. Biochem J 1993;294: 285–92
   PubMed Web of Science ®Google Scholar
• Norgauer J, Metzner B, Schraufstatter I. Expression and growth-promoting function of the IL-8 receptor b in human melanoma cells. J Immunol 1996;156: 1132–7
   PubMed Web of Science ®Google Scholar
• Metzner B, Hofmann C, Heinemann C, Zimpfer U, Schraufstatter I, Schopf E, Norgauer J. Overexpression of CXC-chemokines and CXC-chemokine receptor type II constitute an autocrine growth mechanism in the epidermoid carcinoma cells KB and A431.Oncol Rep 1999;6: 1405–10
   PubMed Web of Science ®Google Scholar
• Fujisawa N, Sakao Y, Hayashi S, Hadden WA 3rd, Harmon CL, Miller EJ. Alpha-chemokine growth factors for adenocarcinomas; a synthetic peptide inhibitor for alpha-chemokines inhibits the growth of adenocarcinoma cell lines. J Cancer Res Clin Oncol 2000;126:19–26
   PubMed Web of Science ®Google Scholar
• Brew R, Erikson JS, West DC, Kinsella AR, Slavin J, Christmas SE. Interleukin-8 as an autocrine growth factor for human colon carcinoma cells in vitro. Cytokine 2000;12:78–85
   PubMed Web of Science ®Google Scholar
• Miyamoto M, Shimizu Y, Okada K, Kashii Y, Higuchi K, Watanabe A. Effect of interleukin-8 on production of tumor-associated substances and autocrine growth of human liver and pancreatic cancer cells. Cancer Immunol Immunother 1998;47:47–57
   PubMed Web of Science ®Google Scholar
• Takamori H, Oades ZG, Hoch OC, Burger M, Schraufstatter IU. Autocrine growth effect of IL-8 and GROalpha on a human pancreatic cancer cell line, Capan-1. Pancreas 2000;21: 52–6
   Google Scholar
• Wang J, Huang M, Lee P, Komanduri K, Sharma S, Chen G, Dubinett SM. Interleukin-8 inhibits non-small cell lung cancer proliferation: a possible role for regulation of tumour growth by autocrine and paracrine pathways. J Interferon Cytok Res 1996;16: 53–60
   Google Scholar
• Ivarsson K, Ekerydh A, Fyhr IM, Janson PO, Brannstrom M. Upregulation of interleukin-8 and polarized epithelial expression of interleukin-8 receptor A in ovarian carcinomas. Acta Obstet Gynecol Scand 2000;79: 777–84
   PubMed Web of Science ®Google Scholar
• Ferrer FA, Pantschenko AG, Miller LJ, Anderson K, Grunnet M, McKenna PH, Kreutzer D. Angiogenesis and neuroblastomas: interleukin-8 and interleukin-8 receptor expression in human neuroblastoma. J Urol 2000;164: 1016–20
   PubMed Web of Science ®Google Scholar
• Richards BL, Eisma RJ, Spiro JD, Lindquist RL, Kreutzer DL. Coexpression of interleukin-8 receptors in head and neck squamous cell carcinoma. Am J Surg 1997;174: 507–12
   PubMed Web of Science ®Google Scholar
• Richmond A, Thomas HG. Purification of melanoma growth stimulatory activity. J Cell Physiol 1986;129:375–84
   PubMed Web of Science ®Google Scholar
• Bordoni R, Fine R, Murray D, Richmond A. Characterisation of the role of melanoma growth stimulating activity (MGSA) in the growth of normal melanocytes, nevocytes and malignant melanocytes. J Cell Biochem 1990;44:207–19
   PubMed Web of Science ®Google Scholar
• Owen JD, Strieter R, Burdick M, Haghnegahdar H, Nanney L, Shattuck-Brandt R, Richmond A. Enhanced tumour-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/ growth-regulated cytokine beta and gamma proteins. Int J Cancer 1997;73:94–103
   PubMed Web of Science ®Google Scholar
• Sehgal A, Keener C, Boynton AL, Warrick J, Murphy GP. CXCR-4, a chemokine receptor, is overexpressed in and required for proliferation of glioblastoma tumor cells. J Surg Oncol 1998;69: 99–104
   PubMed Web of Science ®Google Scholar
• Sehgal A, Ricks S, Boynton AL, Warrick J, Murphy GP. Molecular characterization of CXCR-4: a potential brain tumor-associated gene. J Surg Oncol 1998;69: 239–48
   PubMed Web of Science ®Google Scholar
• Bajetto A, Barbero S, Bonavia R, Piccioli P, Pirani P, Florio T, Schettini G. Stromal cell-derived factor-1alpha induces astrocyte proliferation through the activation of extracellular signal-regulated kinases 1/2 pathway. J Neurochem 2001;77: 1226–36
   PubMed Web of Science ®Google Scholar
• Bajetto A, Bonavia R, Barbero S, Florio T, Schettini G. Chemokines and their receptors in the central nervous system. Front Neuroendocrinol 2001;22:147–84
   PubMed Web of Science ®Google Scholar
• Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1995;1:27–31
   PubMed Web of Science ®Google Scholar
• Norrby K. Angiogenesis: new aspects relating to its initiation and control. APMIS 1997;105:417–37
   PubMed Web of Science ®Google Scholar
• Maione TE, Gray GS, Petro J, Hunt AJ, Donner AL, Bauer SI, Carson HF, Sharpe RJ. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 1990;247:77–9
   PubMed Web of Science ®Google Scholar
• Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, Strieter RM. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992;258:1798–801
   PubMed Web of Science ®Google Scholar
• Strieter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, Dzuiba J, Van Damme J, Walz A, Marriott D, et al. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 1995;270:27348–57
   PubMed Web of Science ®Google Scholar
• Veltri RW, Miller MC, Zhao G, Ng A, Marley GM, Wright GL Jr, Vessella RL, Ralph D. Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer. Urology 1999;53: 139–47
   PubMed Web of Science ®Google Scholar
• Moore BB, Arenberg DA, Stoy K, Morgan T, Addison CL, Morris SB, Glass M, Wilke C, Xue YY, Sitterding S, Kunkel SL, Burdick MD, Strieter RM. Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells. Am J Pathol 1999;154:1503–12
   PubMed Web of Science ®Google Scholar
• Luan J, Shattuck-Brandt R, Haghnegahdar H, Owen JD, Strieter R, Burdick M, Nirodi C, Beauchamp D, Johnson KN, Richmond A. Mechanism and biological significance of constitutive expression of MGSA/GRO chemokines in malignant melanoma tumor progression. J Leukoc Biol 1997;62:588–97
   PubMed Web of Science ®Google Scholar
• Belperio JA, Keane MP, Arenberg DA, Addison CL, Ehlert JE, Burdick MD, Strieter RM. CXC chemokines in angiogenesis. J Leukoc Biol 2000;68:1–8
   PubMed Web of Science ®Google Scholar
• Angiolillo AL, Sgadari C, Taub DD, Liao F, Farber JM, Maheshwari S, Kleinman HK, Reaman GH, Tosato G. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J Exp Med 1995;182: 155–62
   PubMed Web of Science ®Google Scholar
• Sgadari C, Angiolillo AL, Cherney BW, Pike SE, Farber JM, Koniaris LG, Vanguri P, Burd PR, Sheikh N, Gupta G, Teruya-Feldstein J, Tosato G. Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo. Proc Natl Acad Sci USA 1996;93: 13791–6
   PubMed Web of Science ®Google Scholar
• Gupta SK, Lysko PG, Pillarisetti K, Ohlstein E, Stadel JM. Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines. J Biol Chem 1998;273: 4282–7
   PubMed Web of Science ®Google Scholar
• Salcedo R, Wasserman K, Young HA, Grimm MC, Howard OM, Anver MR, Kleinman HK, Murphy WJ, Oppenheim JJ. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: in vivo neovascularization induced by stromal-derived factor-1alpha. Am J Pathol 1999;154: 1125–35
   PubMed Web of Science ®Google Scholar
• Molino M, Woolkalis MJ, Prevost N, Pratico D, Barnathan ES, Taraboletti G, Haggarty BS, Hesselgesser J, Horuk R, Hoxie JA, Brass LF. CXCR4 on human endothelial cells can serve as both a mediator of biological responses and as a receptor for HIV-2. Biochim Biophys Acta 2000;1500: 227–40
   PubMed Web of Science ®Google Scholar
• Moore BB, Keane MP, Addison CL, Arenberg DA, Strieter RM. CXC chemokine modulation of angiogenesis: the importance of balance between angiogenic and angiostatic members of the family. J Investig Med 1998;46:113–20
   PubMed Web of Science ®Google Scholar
• Vihinen P, Kahari VM. Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int J Cancer. 2002;99:157–66
   PubMed Web of Science ®Google Scholar
• Luca M, Huang S, Gershenwald JE, Singh RK, Reich R, Bar-Eli M. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. Am J Pathol 1997;151: 1105–13
   PubMed Web of Science ®Google Scholar
• Bar-Eli M. Role of interleukin-8 in tumor growth and metastasis of human melanoma. Pathobiology 1999;67:12–18
   PubMed Web of Science ®Google Scholar
• Inoue K, Slaton JW, Eve BY, Kim SJ, Perrotte P, Balbay MD, Yano S, Bar-Eli M, Radinsky R, Pettaway CA, Dinney CP. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. Clin Cancer Res 2000;6: 2104–19
   PubMed Web of Science ®Google Scholar
• Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889;1:571–3
   Google Scholar
• Nicolson GL. Paracrine and autocrine growth mechanisms in tumor metastasis to specific sites with particular emphasis on brain and lung metastasis. Cancer Metastasis Rev 1993;12:325–43
   PubMed Web of Science ®Google Scholar
• Stetler-Stevenson WG, Kleiner DE Jr. Molecular biology of cancer: invasion and metastases. In: Devita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology, 6th edn. Philadelphia: Lippincott Williams & Wilkins, 2001:123–36
   Google Scholar
• Keller ET, Zhang J, Cooper CR, Smith PC, McCauley LK, Pienta KJ, Taichman RS. Prostate carcinoma skeletal metastases: crosstalk between tumor and bone. Cancer Metastasis Rev 2001;20:333–49
   PubMed Web of Science ®Google Scholar
• Braun SE, Chen K, Foster RG, Kim CH, Hromas R, Kaplan MH, Broxmeyer HE, Cornetta K. The CC chemokine CK beta-11/ MIP-3 beta/ ELC/ Exodus 3 mediates tumor rejection of murine breast cancer cells through NK cells. J Immunol 2000;164:4025–31
   PubMed Web of Science ®Google Scholar
• Frederick MJ, Clayman GL. Chemokines in cancer. Exp Rev Mol Med 2001;http://www-ermm.cbu.cam.ac.uk/01003301h.htm. Accessed April 2003.
   Google Scholar
• Vicari AP, Ait-Yahia S, Chemin K, Mueller A, Zlotnik A, Caux C. Antitumor effects of the mouse chemokine 6Ckine/SLC through angiostatic and immunological mechanisms. J Immunol 2000;165:1992–2000
   PubMed Web of Science ®Google Scholar
• Sharma S, Stolina M, Luo J, Strieter RM, Burdick M, Zhu LX, Batra RK, Dubinett SM. Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo. J Immunol 2000;164:4558–63
   PubMed Web of Science ®Google Scholar
• Biragyn A, Tani K, Grimm MC, Weeks S, Kwak LW. Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity. Nature Biotechnol 1999;17:253–8
   PubMed Web of Science ®Google Scholar
• White JR, Lee JM, Young PR, Hertzberg RP, Jurewicz AJ, Chaikin MA, Widdowson K, Foley JJ, Martin LD, Griswold DE, Sarau HM. Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. J Biol Chem 1998;273: 10095–8
   PubMed Web of Science ®Google Scholar
• Cammack N. Human immunodeficiency virus type 1 entry and chemokine receptors: a new therapeutic target. Antivir Chem Chemother 1999;10:53–62
   PubMed Web of Science ®Google Scholar
• Zhang YJ, Moore JP. Will multiple coreceptors need to be targeted by inhibitors of human immunodeficiency virus type 1 entry? J Virol 1999;73:3443–8
   PubMed Web of Science ®Google Scholar
• De Clercq E. Inhibition of HIV infection by bicyclams, highly potent and specific CXCR4 antagonists. Mol Pharmacol 2000;57:833–9
   PubMed Web of Science ®Google Scholar
• Hendrix CW, Flexner C, MacFarland RT, Giandomenico C, Fuchs EJ, Redpath E, Bridger G, Henson GW. Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers. Antimicrob Agents Chemother 2000;44:1667–73
   PubMed Web of Science ®Google Scholar
• Murakami T, Nakajima T, Koyanagi Y, Tachibana K, Fujii N, Tamamura H, Yoshida N, Waki M, Matsumoto A, Yoshie O, Kishimoto T, Yamamoto N, Nagasawa T. A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection. J Exp Med 1997;186: 1389–93
   PubMed Web of Science ®Google Scholar
• Murakami T, Zhang TY, Koyanagi Y, Tanaka Y, Kim J, Suzuki Y, Minoguchi S, Tamamura H, Waki M, Matsumoto A, Fujii N, Shida H, Hoxie JA, Peiper SC, Yamamoto N. Inhibitory mechanism of the CXCR4 antagonist T22 against human immunodeficiency virus type 1 infection. J Virol 1999;73: 7489–96
   PubMed Web of Science ®Google Scholar
• Arakaki R, Tamamura H, Premanathan M, Kanbara K, Ramanan S, Mochizuki K, Baba M, Fujii N, Nakashima H. T134, a small-molecule CXCR4 inhibitor, has no cross-drug resistance with AMD3100, a CXCR4 antagonist with a different structure. J Virol 1999;73: 1719–23
   PubMed Web of Science ®Google Scholar
• Doranz BJ, Grovit-Ferbas K, Sharron MP, Mao SH, Goetz MB, Daar ES, Doms RW, O’Brien WA. A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor. J Exp Med 1997;186:1395–400
   PubMed Web of Science ®Google Scholar